RxDoctor Payments Data

Kenneth Faile, MD

Family Medicine · Johnsonville, SCNPI 1750354858

Payments from drug & device makers

$5,116in general payments, 2019–2025

Across 347 payments — averaging $14.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$647
  • Amgen$378
  • Astellas Pharma US Inc$324
  • Novo Nordisk$306
  • Lilly USA, LLC$299
  • plus $2K from 34 others

What the payments were for

  • Food & beverage$5,04299%
  • Education$731%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,116 in reported general payments places this provider in the 85th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$195,373
Medicare patients
401
Services billed
3,273

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide116$150,201
EliquisApixaban135$137,268
OtezlaApremilast15$95,100
MounjaroTirzepatide65$93,459
JardianceEmpagliflozin75$86,838
LinzessLinaclotide87$84,013
JanuviaSitagliptin Phosphate58$73,710
TrulicityDulaglutide65$69,418
FarxigaDapagliflozin Propanediol40$50,186
XareltoRivaroxaban46$49,867
Tresiba Flextouch U-200Insulin Degludec24$45,462
EntrestoSacubitril/Valsartan18$26,101
Repatha SureclickEvolocumab16$21,581
Breo ElliptaFluticasone/Vilanterol32$20,154
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog14$16,653

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$299$162,877130 claims
Novo NordiskOzempic$306$150,201116 claims
PfizerEliquis$237$137,268135 claims
AmgenOtezla$378$95,10015 claims
AbbVieLinzess$1,660$84,01387 claims
MerckJanuvia, Lagevrio (Eua)$14$78,56769 claims
AstraZenecaFarxiga, Breztri Aerosphere$647$62,95253 claims
Johnson & JohnsonXarelto$45$49,86746 claims
GSKBreo Ellipta, Anoro Ellipta$26$29,73958 claims
NovartisEntresto$26$26,10118 claims
Astellas Pharma US IncMyrbetriq$324$13,63623 claims
Scilex Pharmaceuticals Inc.Colchicine$24$7,96367 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Johnsonville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →